Invesco
LEGN icon

Invesco’s Legend Biotech LEGN Stock Holding History

Invesco’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.16M Buy
247,902
+232,607
+1,521% +$6.27M ﹤0.01% 2072
2026
Q1 		$277K Buy
15,295
+1,585
+12% +$30.2K ﹤0.01% 3379
2025
Q4 		$298K Buy
13,710
+581
+4% +$16.6K ﹤0.01% 3384
2025
Q3 		$428K Sell
13,129
-3,701
-22% -$137K ﹤0.01% 3294
2025
Q2 		$597K Sell
16,830
-2,919,873
-99% -$94.6M ﹤0.01% 3082
2025
Q1 		$99.6M Sell
2,936,703
-373,268
-11% -$13.4M 0.02% 803
2024
Q4 		$108M Buy
3,309,971
+1,022,365
+45% +$42.3M 0.02% 794
2024
Q3 		$111M Buy
2,287,606
+2,264,560
+9,826% +$121M 0.02% 769
2024
Q2 		$1.02M Sell
23,046
-92,458
-80% -$4.27M ﹤0.01% 2916
2024
Q1 		$6.48M Sell
115,504
-96,299
-45% -$5.81M ﹤0.01% 2068
2023
Q4 		$12.7M Buy
211,803
+4,041
+2% +$256K ﹤0.01% 1664
2023
Q3 		$14M Buy
207,762
+22,463
+12% +$1.56M ﹤0.01% 1544
2023
Q2 		$12.8M Buy
185,299
+98,668
+114% +$6.45M ﹤0.01% 1634
2023
Q1 		$4.18M Sell
86,631
-27,590
-24% -$1.35M ﹤0.01% 2310
2022
Q4 		$5.7M Buy
114,221
+4,240
+4% +$205K ﹤0.01% 2176
2022
Q3 		$4.49M Buy
109,981
+24,484
+29% +$1.15M ﹤0.01% 2292
2022
Q2 		$4.7M Buy
85,497
+26,001
+44% +$1.1M ﹤0.01% 2320
2022
Q1 		$2.16M Buy
59,496
+1,547
+3% +$61.1K ﹤0.01% 2754
2021
Q4 		$2.7M Buy
+57,949
New +$2.94M ﹤0.01% 2685
2020
Q3 		– Sell
-50,001
Closed -$2.13M – 3666
2020
Q2 		$2.13M Buy
+50,001
New +$1.95M ﹤0.01% 2449

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Invesco's LEGN Position: Q2 2026 in Review

Invesco increased its Legend Biotech (LEGN) stake by 1,521% in Q2 2026, buying an estimated $6.27M and bringing the position to 247,902 shares worth $7.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2072.

Invesco first reported a position in LEGN in Q2 2020 and has held it in 20 quarters since. The position peaked at $111M in Q3 2024. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Invesco held 247,902 shares of Legend Biotech worth $7.16M as of Q2 2026.
  • Invesco bought 232,607 Legend Biotech shares in Q2 2026, an estimated $6.27M.
  • Legend Biotech made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2072 holding.
  • Invesco first reported a position in Legend Biotech in Q2 2020 and has held it in 20 quarters since.
  • Invesco's Legend Biotech position peaked at $111M in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.